In noncritical COVID-19, therapeutic vs. prophylactic anticoagulation did not reduce a composite adverse clinical outcome at 30 d.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 37523703.
- Also identified by DOI 10.7326/J23-0059.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Stone GW, Farkouh ME, Lala A, et al; FREEDOM COVID Anticoagulation Strategy Randomized Trial Investigators. <b>Randomized trial of anticoagulation strategies for noncritically ill patients hospitalized with COVID-19.</b> J Am Coll Cardiol. 2023;81:1747-1762. 36889611.
Medical subject headings
- COVID-19